Nutritional Omega-3 deficiency alters glucocorticoid receptor-signaling pathway and neuronal morphology in regionally distinct brain structures associated with emotional deficits

Neural Plasticity

Volumn 2016, Issue , 2016, Pages

  Larrieu, Thomas ^a,b,c   Hilal, Muna L ^b,d   De Smedt Peyrusse, Véronique ^a,b   Sans, Nathalie ^b,d   Layé, Sophie ^a,b  

^a NutriNeuro Bordeaux University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c EPFL   (Switzerland)

^d INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; OMEGA 3 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN CELL; BRAIN REGION; CELL STRUCTURE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DENDRITIC CELL; EMOTIONAL DISORDER; ESSENTIAL FATTY ACID DEFICIENCY; GENE EXPRESSION; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; ANIMAL; CELL SHAPE; CYTOLOGY; EMOTION; HIPPOCAMPUS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANIMALS; CELL SHAPE; EMOTIONS; FATTY ACIDS, OMEGA-3; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; NEURONS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84957065821     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2016/8574830     Document Type: Article

References (34)

1. M. Lafourcade, T. Larrieu, S. Mato et al., "Nutritional omega-deficiency abolishes endocannabinoid-mediated neuronal functions," Nature Neuroscience, vol. 14, no. 3, pp. 345-350, 2011.
2. S. Maccari and S. Morley-Fletcher, "Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations," Psychoneuroendocrinology, vol. 32, supplement 1, pp. S10-S15, 2007.
3. D. Cao, K. Kevala, J. Kim et al., "Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function," Journal of Neurochemistry, vol. 111, no. 2, pp. 510-521, 2009.
4. J. R. Hibbeln, "Fish consumption and major depression," The Lancet, vol. 351, no. 9110, p. 1213, 1998.
5. A. P. Simopoulos, "The importance of the ratio of omega-6/omega-3 essential fatty acids," Biomedicine and Pharmacotherapy, vol. 56, no. 8, pp. 365-379, 2002.
6. A. P. Simopoulos, "Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications," World Review of Nutrition and Dietetics, vol. 100, pp. 1-21, 2009.
7. P. B. Adams, S. Lawson, A. Sanigorski, and A. J. Sinclair, "Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression," Lipids, vol. 31, no. 1, pp. S157-S161, 1996.
8. P. Green, H. Hermesh, A. Monselise, S. Marom, G. Presburger, and A. Weizman, "Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder," EuropeanNeuropsychopharmacology, vol. 16, no. 2, pp. 107-113, 2006.
9. R. K. McNamara and Y. Liu, "Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder," Journal of Affective Disorders, vol. 129, no. 1-3, pp. 359-363, 2011.
10. C. O. Bondi, A. Y. Taha, J. L. Tock et al., "Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency," Biological Psychiatry, vol. 75, no. 1, pp. 38-46, 2014.
11. T. Takeuchi, M. Iwanaga, and E. Harada, "Possible regulatory mechanism of DHA-induced anti-stress reaction in rats," Brain Research, vol. 964, no. 1, pp. 136-143, 2003.
12. J. C. Jr. DeMar, K. Ma, J. M. Bell, M. Igarashi, D. Greenstein, and S. I. Rapoport, "One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats,"The Journal of Lipid Research, vol. 47, no. 1, pp. 172-180, 2006.
13. G. P. Chrousos, "Stress and disorders of the stress system," Nature Reviews Endocrinology, vol. 5, no. 7, pp. 374-381, 2009.
14. E. R. de Kloet, "From receptor balance to rational glucocorticoid therapy," Endocrinology, vol. 155, no. 8, pp. 2754-2769, 2014.
15. C. B. Nemeroff, E. Widerlov, G. Bissette et al., "Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients," Science, vol. 226, no. 4680, pp. 1342-1344, 1984.
16. M. Niwa, H. Jaaro-Peled, S. Tankou et al., "Adolescent stressinduced epigenetic control of dopaminergic neurons via glucocorticoids," Science, vol. 339, no. 6117, pp. 335-339, 2013.
17. F. Holsboer, "The corticosteroid receptor hypothesis of depression," Neuropsychopharmacology, vol. 23, no. 5, pp. 477-501, 2000.
18. R. P. Bazinet and S. Layé, "Polyunsaturated fatty acids and theirmetabolites in brain function and disease," Nature Reviews Neuroscience, vol. 15, pp. 771-785, 2014.
19. T. Larrieu, L. M. Hilal, C. Fourrier et al., "Nutritional omega-modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion," Translational Psychiatry, vol. 4, article e437, 2014.
20. T. Larrieu, C. Madore, C. Joffre, and S. Layé, "Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxietylike behavior in mice," Journal of Physiology and Biochemistry, vol. 68, no. 4, pp. 671-681, 2012.
21. R. Mingam, A. Moranis, R.-M. Bluthé et al., "Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice," European Journal of Neuroscience, vol. 28, no. 9, pp. 1877-1886, 2008.
22. S. Ridder, S. Chourbaji, R. Hellweg et al., "Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions," The Journal of Neuroscience, vol. 25, no. 26, pp. 6243-6250, 2005.
23. C. Anacker, P. A. Zunszain, L. A. Carvalho, and C. M. Pariante, "The glucocorticoid receptor: pivot of depression and of antidepressant treatment?" Psychoneuroendocrinology, vol. 36, no. 3, pp. 415-425, 2011.
24. R. S. Lee, K. L. K. Tamashiro, X. Yang et al., "A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice," Psychopharmacology, vol. 218, no. 1, pp. 303-312, 2011.
25. S. K. Godavarthi, P. Dey, M. Maheshwari, and N. R. Jana, "Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome," Human Molecular Genetics, vol. 21, no. 8, pp. 1824-1834, 2012.
26. J. Barik, F. Marti, C. Morel et al., "Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons," Science, vol. 339, no. 6117, pp. 332-335, 2013.
27. M. L. Lehmann, R. A. Brachman, K. Martinowich, R. J. Schloesser, and M. Herkenham, "Glucocorticoids orchestrate divergent effects on mood through adult neurogenesis," The Journal of Neuroscience, vol. 33, no. 7, pp. 2961-2972, 2013.
28. D. Suri and V. A. Vaidya, "Glucocorticoid regulation of brainderived neurotrophic factor: relevance to hippocampal structural and functional plasticity," Neuroscience, vol. 239, pp. 196-213, 2013.
29. M. N. Hill, C. J. Hillard, and B. S. McEwen, "Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress," Cerebral Cortex, vol. 21, no. 9, pp. 2056-2064, 2011.
30. M. N. Hill, S. A. Kumar, S. B. Filipski et al., "Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure," Molecular Psychiatry, vol. 18, no. 10, pp. 1125-1135, 2013.
31. J. P. Herman, M. M. Ostrander, N. K. Mueller, and H. Figueiredo, "Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 29, no. 8, pp. 1201-1213, 2005.
32. E. B. Binder, "The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders," Psychoneuroendocrinology, vol. 34, no. 1, pp. S186-S195, 2009.
33. N. Fani, D. Gutman, E. B. Tone et al., "FKBP5 and attention bias for threat: associations with hippocampal function and shape," JAMA Psychiatry, vol. 70, no. 4, pp. 392-400, 2013.
34. S. Pietropaolo, M. G. Goubran, C. Joffre et al., "Dietary supplementation of omega-3 fatty acids rescues fragile X phenotypes in Fmr1-Ko mice," Psychoneuroendocrinology, vol. 49, no. 1, pp. 119-129, 2014.